Cardiovascular Systems (CSII) Stock Analysis

What Cardiovascular Systems does

Cardiovascular Systems, Inc. (CSI) is a medical technology firm dedicated to the creation and commercialization of advanced therapeutic solutions for individuals suffering from peripheral and coronary artery diseases, serving markets both within the United States and internationally. For peripheral artery disease (PAD), CSI offers a range of catheter-based systems designed to treat various types of arterial plaque, including severely calcified deposits, in arteries located both above and below the knee. These systems aim to provide improved outcomes compared to conventional surgical, interventional, and pharmacological treatments. The company also provides supplementary peripheral support products. Regarding coronary artery disease (CAD), CSI supplies the Diamondback 360 Coronary Orbital Atherectomy System (OAS). This specialized device is engineered to aid in the successful placement of stents in CAD patients who present with heavily calcified coronary artery lesions and are deemed suitable candidates for percutaneous transluminal coronary angioplasty or stenting procedures. Furthermore, CSI manufactures and distributes essential procedural accessories such as guidewires, catheters, balloons, and embolic protection systems, along with other supporting products for its OAS technology. In a collaborative effort, Cardiovascular Systems, Inc. has partnered with Chansu Vascular Technologies, LLC, focusing on the development of innovative everolimus drug-coated balloons for both peripheral and coronary applications. Originally established in 1989 as Shturman Cardiology Systems, Inc., the company officially adopted its current name, Cardiovascular Systems, Inc., in January 2003. Its corporate headquarters are located in Saint Paul, Minnesota.

Key metrics

ETFs linked to CSII

Broad-market and Healthcare sector ETFs an investor holding Cardiovascular Systems is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CSII fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Cardiovascular Systems?

Cardiovascular Systems trades under the ticker CSII on NASDAQ.

Which exchange is CSII listed on?

CSII is listed on NASDAQ.

What sector does Cardiovascular Systems operate in?

Cardiovascular Systems is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze CSII in a portfolio?

PortView shows CSII's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.